Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term UNITED-STATES. Found 12 abstracts

Marur S, Burtness B. Oropharyngeal squamous cell carcinoma treatment: current standards and future directions. Current Opinion in Oncology. 2014 May;26(3):252-8.   PMCID: No NIH funding
Cooper JS, Porter K, Mallin K, Hoffman HT, Weber RS, Ang KK, Gay EG, Langer CJ. National cancer Database report on cancer of the head and neck: 10-year update. Head and Neck-Journal for the Sciences and Specialties of the Head and Neck. 2009 Jun;31(6):748-58.
Daniel LC, Heckman CJ, Kloss JD, Manne SL. Comparing alternative methods of measuring skin color and damage. Cancer Causes & Control. 2009 Apr;20(3):313-21.   PMCID: PMC2702995
Satia JA, Tseng M, Galanko JA, Martin C, Sandler RS. Dietary Patterns and Colon Cancer Risk in Whites and African Americans in the North Carolina Colon Cancer Study. Nutrition and Cancer-an International Journal. 2009 Jan;61(2):179-93.   PMCID: NIHMS 176444
Glanz K, Yaroch AL, Dancel M, Saraiya M, Crane LA, Buller DB, Manne S, O'Riordan DL, Heckman CJ, Hay J, Robinson JK. Measures of sun exposure and sun protection practices for behavioral and epidemiologic research. Archives of Dermatology. 2008 Feb;144(2):217-22.
Hassett MJ, Hughes ME, Niland JC, Ottesen R, Edge SB, Bookman MA, Carlson RW, Theriault RL, Weeks JC. Selecting high priority quality measures for breast cancer quality improvement. Medical Care. 2008 Aug;46(8):762-70.
Lazovich D, Stryker JE, Mayer JA, Hillhouse J, Dennis LK, Pichon L, Pagoto S, Heckman C, Olson A, Cokkinides V, Thompson K. Measuring nonsolar tanning behavior - Indoor and sunless tanning. Archives of Dermatology. 2008 Feb;144(2):225-30.
Simon GR, Verschraegen CF, Janne PA, Langer CJ, Dowlati A, Gadgeel SM, Kelly K, Kalemkerian GP, Traynor AM, Peng G, Gill J, Obasaju CK, Kindler HL. Pemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma: Final report of a phase II trial. Journal of Clinical Oncology. 2008 Jul;26(21):3567-72.
Apicella C, Dowty JG, Dite GS, Jenkins MA, Senle RT, Daly MB, Andrulis IL, John EM, Buys SS, Li FP, Glendon G, Chung W, Ozcelik H, Miron A, Kotar K, Southey MC, Foulkes WD, Hopper JL. Validation study of the LAMBDA model for predicting the BRCA1 or BRCA2 mutation carrier status of North American Ashkenazi Jewish women. Clinical genetics. 2007 Aug;72(2):87-97.
Katz SJ, Hofer TP, Hawley S, Lantz PM, Janz NK, Schwartz K, Liu L, Deapen D, Morrow M. Patterns and correlates of patient referral to surgeons for treatment of breast cancer. Journal of Clinical Oncology. 2007 Jan;25(3):271-6.
Comunale MA, Mattu TS, Lowman MA, Evans AA, London WT, Semmes OJ, Ward M, Drake R, Romano PR, Steel LF, Block TM, Mehta A. Comparative proteomic analysis of de-N-glycosylated serum from hepatitis B carriers reveals polypeptides that correlate with disease status. Proteomics. 2004 Mar;4(3):826-38.
Bruner DW, Moore D, Parlanti A, Dorgan J, Engstrom P. Relative risk of prostate cancer for men with affected relatives: systematic review and meta-analysis. International journal of cancer. 2003 Dec 10;107(5):797-803.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term UNITED-STATES

UNITED-STATES TRENDS ADULTS CARCINOMA ADOLESCENTS PREVALENCE CANCER SUNBURN HUMAN-PAPILLOMAVIRUS RISK KeyWords Plus: quality improvement HEAD CONCURRENT CHEMORADIOTHERAPY COHORT EXPOSURE CARE QUALITY meta-analysis 2-DIMENSIONAL GEL-ELECTROPHORESIS CHROMOSOME de-escalation THERAPY hepatocellular carcinoma prostate cancer risk IMMOBILIZED PH GRADIENTS hereditary prostate cancer GUIDELINES POPULATION-BASED COHORT ULTRAVIOLET-RADIATION EXPOSURE NCCN NUTRITIONAL EPIDEMIOLOGY INDICATORS breast cancer COMBINATION FAMILY HISTORY OVARIAN-CANCER clinical practice guidelines head and neck squamous cell cancer CONSERVING SURGERY SUSCEPTIBILITY GENES ovarian Spectrophotometry JEWS Ashkenazi Jewish BREAST-CANCER RATES mutations HABITUAL PHYSICAL-ACTIVITY OF-CARE hepatitis B GENE EFFICACY PHENOTYPE STATISTICS BRCA2 national cancer database RISKS GLYCOPROTEINS diagnostic markers nationwide novel targets in SKIN-CANCER LIFE-STYLE EXPERIENCE PAY-FOR-PERFORMANCE MORTALITY glycosylation human papilloma virus COLORECTAL-CANCER GERMLINE MUTATIONS HEALTH-CARE REFLECTANCE HEALTH-RISK BEHAVIORS PROGRAM SWEDEN TONSIL cancer TRIAL MALIGNANT PLEURAL MESOTHELIOMA RANDOMIZED PHASE-II SUN PROTECTION BEHAVIORS LOCAL THERAPY chemoradiation NECK-CANCER EPIDEMIOLOGY DISCOVERY breast cancer and medical intervention Reproducibility of results BRCA1 CISPLATIN CERULOPLASMIN demographics BREAST-CANCER PATIENTS VOLUME SUSCEPTIBILITY LOCUS 185DELAG quality measurement Oncology oropharynx cancer QUESTIONNAIRE COMMON BRCA1 MELANOMA CARE ORGANIZATIONS ORAL-CAVITY HEPATOCELLULAR-CARCINOMA smoking MASS-SPECTROMETRY COOPERATIVE-ONCOLOGY-GROUP two-dimensional gel electrophoresis 7-DAY RECALL APPEARANCE-BASED INTERVENTIONS PERFORMANCE LIQUID-CHROMATOGRAPHY head and neck cancer BASAL-CELL PANCREATIC-CANCER PROTEINS OUTCOMES INTRAPERITONEAL CHEMOTHERAPY
Last updated on Friday, January 03, 2020